UHD's science building has received funding from a nonprofit affiliate of Green Mountain Energy to install green energy technology. Courtesy of NRG

The University of Houston-Downtown has gotten some green to make its new College of Sciences & Technology Building even more green.

The Green Mountain Energy Sun Club, a nonprofit affiliated with the Green Mountain Energy utility provider, has pledged more than $250,000 to UHD for installation of solar panels at the building, as well as the purchase of photosynthesis equipment.

Akif Uzman, dean of UHD's College of Sciences & Technology, says in a release that the Green Mountain Energy Sun Club gift propels "our drive to show students and our local community our commitment to energy conservation and sustainable energy practices."

By the spring of 2020, UHD will install a 54-panel, 16.7-kilowatt, off-grid solar system that will help power two environmental science teaching labs in the College of Sciences & Technology Building. One of the labs, the Green Mountain Energy Sun Club Environmental Science Lab, will host classes by next year's spring semester.

"Our mission is to change the way power is made, and we share UHD's dedication to renewable energy, environmental education, and reducing carbon emissions," Mark Parsons, vice president and general manager of Houston-based Green Mountain Energy, says in a release.

Houston-based NRG Energy owns Green Mountain Energy.

Donations to the Sun Club come from Green Mountain Energy and its customers and employees. Since 1997, Green Mountain Energy has promoted energy efficiency, conservation, and environmental stewardship.

The Sun Club gift also will help buy a portable photosynthesis system. Michael Tobin, associate professor of biology, says the equipment will take measurements of plants in courses such as Plant Biology Laboratory, General Ecology Laboratory, and Environmental Lab and Field Studies. In addition, it will be used by students conducting faculty-guided research projects.

"A research-grade instrument to make photosynthesis and water use measurements will enhance students' research experiences and increase the likelihood that their project results can be published in a peer-reviewed scientific journal," Tobin says in a release.

UHD opened the College of Sciences & Technology Building in August. It's the first University of Houston System building constructed to meet LEED Gold standards, reflecting a commitment to sustainability features such as energy-efficient lighting, recycled construction materials, and "smart" design components.

Spanning 105,000 square feet, the College of Sciences & Technology Building contains nearly 30 labs for teaching and research, as well as classrooms, meeting and study spaces, and a café. UHD envisions the building will be a "model for sustainability in Houston."

Environmental highlights of the building include a 6,000-gallon cistern that provides water for the outdoor urban gardens, and the addition of native grasses in the surrounding landscape to create a micro-pocket prairie and, in effect, an outdoor classroom.

Aside from classes and resources for students and faculty in biology, biotechnology, biological and physical sciences, and chemistry, the building houses UHD's Center for Urban Agriculture & Sustainability.

The center is "a game changer for UHD initiatives and scholarly activities centered on sustainability," Lisa Morano, director of the Center for Urban Agriculture & Sustainability, says in a release. "It also serves as an example of how planners and architects can incorporate environmentally sound decisions in the design and construction of academic facilities."

Juan Sánchez Muñoz, president of UHD, says the College of Sciences & Technology Building is a hub for academic exploration and a catalyst for community collaboration.

"Its labs and learning spaces will elevate UHD's ability to prepare the next generation of Houston's scientists and innovators. The facility also will serve as a place where Houstonians can gather to address issues affecting our city and to learn how UHD is leading positive change in the region," Muñoz says in a release. "It's a major addition to our campus and an incredible asset to Houston."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas tops ranking of best state for investors in new report

by the numbers

Texas ranks third on a new list of the best states for investors and startups.

Investment platform BrokerChooser weighed five factors to come up with its ranking:

  • 2024 Google search volume for terms related to investing
  • Number of investors
  • Number of businesses receiving investments in 2024
  • Total amount of capital invested in businesses in 2024
  • Percentage change in amount of investment from 2019 to 2024

Based on those figures, provided mostly by Crunchbase, Texas sits at No. 3 on the list, behind No. 1 California and No. 2 New York.

Especially noteworthy for Texas is its investment total for 2024: more than $164.5 billion. From 2019 to 2024, the state saw a 440 percent jump in business investments, according to BrokerChooser. The same percentages are 204 percent for California and 396 percent for New York.

“There is definitely development and diversification in the American investment landscape, with impressive growth in areas that used to fly under the radar,” says Adam Nasli, head analyst at BrokerChooser.

According to Crunchbase, funding for Texas startups is off to a strong start in 2025. In the first three months of this year, venture capital investors poured nearly $2.9 billion into Lone Star State companies, Crunchbase data shows. Crunchbase attributes that healthy dollar amount to “enthusiasm around cybersecurity, defense tech, robotics, and de-extincting mammoths.”

During the first quarter of this year, roughly two-thirds of VC funding in Texas went to just five companies, says Crunchbase. Those companies are Austin-based Apptronik, Austin-based Colossal Biosciences, Dallas-based Island, Austin-based NinjaOne, and Austin-based Saronic.

Autonomous truck company rolls out driverless Houston-Dallas route

up and running

Houston is helping drive the evolution of self-driving freight trucks.

In October, Aurora opened a more than 90,000-square-foot terminal at a Fallbrook Drive logistics hub in northwest Houston to support the launch of its first “lane” for driverless trucks—a Houston-to-Dallas route on the Interstate 45 corridor. Aurora opened its Dallas-area terminal in April and the company began regular driverless customer deliveries between the two Texas cities on April 27.

Close to half of all truck freight in Texas moves along I-45 between Houston and Dallas.

“Now, we are the first company to successfully and safely operate a commercial driverless trucking service on public roads. Riding in the back seat for our inaugural trip was an honor of a lifetime – the Aurora Driver performed perfectly and it’s a moment I’ll never forget,” Chris Urmson, CEO and co-founder of Pittsburgh-based Aurora, said in a news release.

Aurora produces software that controls autonomous vehicles and is known for its flagship product, the Aurora Driver. The software is installed in Volvo and Paccar trucks, the latter of which includes brands like Kenworth and Peterbilt.

Aurora previously hauled more than 75 loads per week under the supervision of vehicle operators from Houston to Dallas and Fort Worth to El Paso for customers in its pilot project, including FedEx, Uber Freight and Werner. To date, it has completed over 1,200 miles without a driver.

The company launched its new Houston to Dallas route with customers Uber Freight and Hirschbach Motor Lines, which ran supervised commercial pilots with Aurora.

“Transforming an old school industry like trucking is never easy, but we can’t ignore the safety and efficiency benefits this technology can deliver. Autonomous trucks aren’t just going to help grow our business – they’re also going to give our drivers better lives by handling the lengthier and less desirable routes,” Richard Stocking, CEO of Hirschbach Motor Lines, added in the statement.

The company plans to expand its service to El Paso and Phoenix by the end of 2025.

“These new, autonomous semis on the I-45 corridor will efficiently move products, create jobs, and help make our roadways safer,” Gov. Greg Abbott added in the release. “Texas offers businesses the freedom to succeed, and the Aurora Driver will further spur economic growth and job creation in Texas. Together through innovation, we will build a stronger, more prosperous Texas for generations.”

In July, Aurora said it raised $820 million in capital to fuel its growth—growth that’s being accompanied by scrutiny.

In light of recent controversies surrounding self-driving vehicles, the International Brotherhood of Teamsters, whose union members include over-the-road truckers, recently sent a letter to Lt. Gov. Dan Patrick calling for a ban on autonomous vehicles in Texas.

“The Teamsters believe that a human operator is needed in every vehicle—and that goes beyond partisan politics,” the letter states. “State legislators have a solemn duty in this matter to keep dangerous autonomous vehicles off our streets and keep Texans safe. Autonomous vehicles are not ready for prime time, and we urge you to act before someone in our community gets killed.”

Houston cell therapy company launches second-phase clinical trial

fighting cancer

A Houston cell therapy company has dosed its first patient in a Phase 2 clinical trial. March Biosciences is testing the efficacy of MB-105, a CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma.

Last year, InnovationMap reported that March Biosciences had closed its series A with a $28.4 million raise. Now, the company, co-founded by Sarah Hein, Max Mamonkin and Malcolm Brenner, is ready to enroll a total of 46 patients in its study of people with difficult-to-treat cancer.

The trial will be conducted at cancer centers around the United States, but the first dose took place locally, at The University of Texas MD Anderson Cancer Center. Dr. Swaminathan P. Iyer, a professor in the department of lymphoma/myeloma at MD Anderson, is leading the trial.

“This represents a significant milestone in advancing MB-105 as a potential treatment option for patients with T-cell lymphoma who currently face extremely limited therapeutic choices,” Hein, who serves as CEO, says. “CAR-T therapies have revolutionized the treatment of B-cell lymphomas and leukemias but have not successfully addressed the rarer T-cell lymphomas and leukemias. We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.”

The Phase 1 trial showed promise for MB-105 in terms of both safety and efficacy. That means that potentially concerning side effects, including neurological events and cytokine release above grade 3, were not observed. Those results were published last year, noting lasting remissions.

In January 2025, MB-105 won an orphan drug designation from the FDA. That results in seven years of market exclusivity if the drug is approved, as well as development incentives along the way.

The trial is enrolling its single-arm, two-stage study on ClinicalTrials.gov. For patients with stubborn blood cancers, the drug is providing new hope.